Abstract |
Matrix metalloproteinases are particularly potent in degrading basement membrane collagen and other extracellular matrix components. We have investigated the effects of a selective phosphodiesterase 4 inhibitor, RP 73-401 [N-(3, 5-dichloropyrid-4-yl)-3-cyclopentyloxy-4-methoxybenzamide], on gelatinase ( matrix metalloproteinase-2 and matrix metalloproteinase-9) activity in ovalbumin-sensitized and -challenged mice. Twenty-four hours after the last challenge, matrix metalloproteinase activity was evaluated in the bronchoalveolar lavage fluids by a zymography technique, and a significant increase in matrix metalloproteinase-9, but not matrix metalloproteinase-2, activity was noted. When administered orally (0.3-3 mg/kg) 1 h before each ovalbumin challenge, the selective phosphodiesterase 4 inhibitor, RP 73-401, significantly reduced this increased matrix metalloproteinase-9 activity in bronchoalveolar lavage fluids. Our data suggest that RP 73-401 may modulate tissue remodelling associated with lung inflammatory processes including asthma.
|
Authors | C Belleguic, M Corbel, N Germain, E Boichot, P Delaval, V Lagente |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 404
Issue 3
Pg. 369-73
(Sep 22 2000)
ISSN: 0014-2999 [Print] Netherlands |
PMID | 10996602
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Benzamides
- Phosphodiesterase Inhibitors
- Pyridines
- 3',5'-Cyclic-AMP Phosphodiesterases
- Cyclic Nucleotide Phosphodiesterases, Type 4
- Matrix Metalloproteinase 2
- Matrix Metalloproteinase 9
- piclamilast
|
Topics |
- 3',5'-Cyclic-AMP Phosphodiesterases
(antagonists & inhibitors, metabolism)
- Animals
- Benzamides
(pharmacology)
- Bronchoalveolar Lavage Fluid
- Cyclic Nucleotide Phosphodiesterases, Type 4
- Male
- Matrix Metalloproteinase 2
(drug effects, metabolism)
- Matrix Metalloproteinase 9
(drug effects, metabolism)
- Mice
- Mice, Inbred BALB C
- Phosphodiesterase Inhibitors
(pharmacology)
- Pyridines
(pharmacology)
|